Cor triatriatum
| Cor triatriatum | |
|---|---|
| Synonyms | Triatrial heart |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Shortness of breath, fatigue, palpitations, chest pain |
| Complications | Heart failure, pulmonary hypertension, atrial fibrillation |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Congenital heart defect |
| Risks | Congenital heart disease |
| Diagnosis | Echocardiography, MRI, CT scan |
| Differential diagnosis | Atrial septal defect, mitral stenosis |
| Prevention | N/A |
| Treatment | Surgical resection, balloon atrial septostomy |
| Medication | N/A |
| Prognosis | Variable, depending on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Cor triatriatum is a rare congenital heart defect where the left atrium or the right atrium is divided into two parts by a fold of tissue, a membrane, or a fibromuscular band.
Overview[edit]
Cor triatriatum represents 0.1% of all congenital heart diseases. The condition can occur on its own or in association with other cardiac anomalies, such as atrial septal defect, ventricular septal defect, patent ductus arteriosus, and anomalous pulmonary venous connection.
Symptoms[edit]
The symptoms of cor triatriatum depend on the size of the opening in the fibromuscular membrane and whether other heart defects are present. Symptoms may include shortness of breath, fatigue, palpitations, and cyanosis.
Diagnosis[edit]
Cor triatriatum is typically diagnosed using echocardiography, which can visualize the abnormal membrane and assess its hemodynamic significance. Other diagnostic tests may include cardiac catheterization, computed tomography (CT) scan, and magnetic resonance imaging (MRI).
Treatment[edit]
The treatment for cor triatriatum is surgical removal of the abnormal membrane to restore normal blood flow. The prognosis after surgery is generally good, with most patients experiencing a significant improvement in symptoms and quality of life.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


